Comparison of Long-Term Clinical Outcomes After Drug-Eluting Stenting in Blacks-vs-Whites

Stephen G Ellis,Leslie Cho,Russell Raymond,Ravi Nair,Conrad Simpfendorfer,Murat Tuzcu,Christopher Bajzer,Abraham Michael Lincoff,Samir Kapadia,Stephen G. Ellis
DOI: https://doi.org/10.1016/j.amjcard.2019.07.020
IF: 3.133
2019-10-01
The American Journal of Cardiology
Abstract:Patients of different racial backgrounds may have socioeconomic, cultural, or genetic differences that impact outcomes after PCI. There are limited data beyond 2-3 years for Blacks to inform discussions and perhaps improve outcomes. We studied consecutive limus-stent treated patients, having their first PCI at our institution 1/2003-3/2010 in 2 cohorts; Cohort 1: standard 3 year follow-up (n=3782, 12.4% Blacks) and Cohort 2: from nearby zip codes with intended detailed follow up through 8-13 years (n=616, 31.8% Blacks). The primary outcomes of interest were mortality and death/MI/revascularization (DMIR) (Cohort 1) or MACE (cardiac death/MI/revascularization)(Cohort 2). In all cohorts, Blacks had a higher prevalence of many risk factors. In Cohort 1, 3 year mortalities were 14.6% and 9.6% (p=0.001) and DMIR were 32.1% and 25.0% (p=0.001), for Blacks and Whites, respectively. In Cohort 2, over 9.5±2.0 years, treatment intensity was as high or higher for Blacks, but they continued to have higher LDL-cholesterol and blood pressure values. MACE and mortality at 10 years were higher for Blacks (59.0% vs 48.1%, p=0.024 and 44.3% vs 23.0%, p<0.001). Differences in outcomes, except 10 year mortality, were not significantly different after adjustment for baseline characteristics. Blacks have a higher risk profile at the time of PCI and worse long term outcomes after DES, most of which is explained by baseline differences.
cardiac & cardiovascular systems
What problem does this paper attempt to address?